Performa Ltd (US), LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 112 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Performa Ltd (US), LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$9,163
-18.4%
4,900
-94.6%
0.01%
-16.7%
Q1 2023$11,223
+55.7%
90,000
+28.6%
0.01%
+50.0%
Q4 2022$7,210
-19.9%
70,000
+16.7%
0.00%
-33.3%
Q3 2022$9,000
-66.7%
60,000
+94.4%
0.01%
-70.0%
Q2 2022$27,000
-43.8%
30,859
-5.0%
0.02%
+25.0%
Q1 2022$48,000
+140.0%
32,500
+225.0%
0.02%
+33.3%
Q4 2021$20,000
+300.0%
10,000
+400.0%
0.01%
+300.0%
Q3 2021$5,0000.0%2,000
+17.6%
0.00%0.0%
Q2 2021$5,0001,7000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders